RJ 7183
Alternative Names: RJ-7183Latest Information Update: 20 Sep 2023
At a glance
- Originator Nanjing Ruijie Pharma
- Class Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis
Most Recent Events
- 07 Jul 2023 Preclinical trials in Non-alcoholic steatohepatitis in China (PO), prior to July 2023 (Nanjing Ruijie Pharmaceuticals pipeline, July 2023)